ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Hydrochloric Acid → (1R,2S)-5'-methoxy-2-(3-(4-(4-methylpiperazin-1-yl)phenyl)-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-one hydrochloride

HRID 447523
印刷

反応式

HRID 447523 の反応式
IC1C2C(=CC([C@H]3[C@@]4(C5C(=CC=C(OC)C=5)NC4=O)C3)=CC=2)NN=1.CN1CCN(C2C=CC(B3OC(C)(C)C(C)(C)O3)=CC=2)CC1.[Li+].[Cl-:48].C([O-])([O-])=O.[Na+].[Na+].[I-].Cl.[CH3:57][O:58][C:59]1[CH:60]=[C:61]2[C:65](=[CH:66][CH:67]=1)[NH:64][C:63](=[O:68])[C@:62]12[CH2:70][C@H:69]1[C:71]1[CH:79]=[C:78]2[C:74]([C:75]([C:80]3[CH:85]=[CH:84][C:83]([N:86]4[CH2:91][CH2:90][N:89]([CH3:92])[CH2:88][CH2:87]4)=[CH:82][CH:81]=3)=[N:76][NH:77]2)=[CH:73][CH:72]=1>O1CCOCC1.C1COCC1.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[ClH:48].[CH3:57][O:58][C:59]1[CH:60]=[C:61]2[C:65](=[CH:66][CH:67]=1)[NH:64][C:63](=[O:68])[C@:62]12[CH2:70][C@H:69]1[C:71]1[CH:79]=[C:78]2[C:74]([C:75]([C:80]3[CH:81]=[CH:82][C:83]([N:86]4[CH2:87][CH2:88][N:89]([CH3:92])[CH2:90][CH2:91]4)=[CH:84][CH:85]=3)=[N:76][NH:77]2)=[CH:73][CH:72]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

11

反応物 7

HCID 313Hydrochloric AcidHCID 10340Sodium CarbonateHCID 30165Iodide IonHCID 433294Lithium ChlorideHCID 179989051-Methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazineHCID 58486186(1R,2S)-5'-methoxy-2-(3-(4-(4-methylpiperazin-1-yl)phenyl)-1H-indazol-6-yl)spiro [cyclopropane-1,3'-indolin]-2'-one
HCID 178487035
HCID 178487035、化合物

生成物 1

HCID 67445846(1R,2S)-5'-methoxy-2-(3-(4-(4-methylpiperazin-1-yl)phenyl)-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-one hydrochloride収率 99.2%

試薬・触媒・溶媒 3

HCID 178418397HCID 178418397、化合物触媒HCID 8028Tetrahydrofuran溶媒HCID 312751,4-Dioxane溶媒

実験手順

A mixture of (1R,2S)-2-(3-iodo-1H-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (540 mg, 1.25 mmol), 1-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine (416 mg, 1.38 mmol), Pd(PPh3)4 (7 mg, 0.06 mmol), LiCl (159 mg, 3.75 mmol) and 1M Na2CO3 (6.3 mL, 6.3 mmol) in dioxane (20 mL) was heated to reflux in an oil bath until the iodide had been consumed as determined by LCMS. The reaction was then allowed to cool to room temperature and was diluted with EtOAc and water was added. The resulting mixture was extracted with EtOAc and the combined organic extracts were washed with brine, dried over MgSO4 and concentrated to give an orange solid. The title compound was purified by silica gel chromatography (95:3:2 to 85:13:2 CH2Cl2/MeOH/NH3) to yield a yellow solid. HCl (1M in diethyl ether, 3.1 mL, 3.1 mmol) was added in a dropwise manner to a solution of (1R,2S)-5′-methoxy-2-(3-(4-(4-methylpiperazin-1-yl)phenyl)-1H-indazol-6-yl)spiro [cyclopropane-1,3′-indolin]-2′-one (240 mg, 0.500 mmol) in THF (1 mL). A yellow precipitate formed and the solid was then filtered and washed with ether (2 mL) giving the title compound (256 mg, 42%). 1H NMR (400 MHz, CD3OD) δ 7.94 (d, J=8.2 Hz, 1H), 7.88 (d, J=8.4 Hz, 2H), 7.52 (s, 1H), 7.19 (d, J=8.6 Hz, 2H), 7.05 (d, J=8.2 Hz, 1H), 6.84 (d, J=8.4 Hz, 1H), 6.62 (d, J=7.7 Hz, 1H), 5.62 (s, 1H), 4.01-3.98 (m, 2H), 3.67-3.64 (m, 2H), 3.39-3.32 (m, 3H), 3.28 (s, 3H), 3.18-3.11 (m, 2H), 3.00 (s, 3H), 2.28-2.25 (m, 1H), 2.21-2.18 (m, 1H); MS ESI 480.4 [M+H]+, calcd for [C29H29N5O2+H]+ 480.23.

後処理

  1. temperaturewas heated
  2. customhad been consumed
  3. additionwas diluted with EtOAc and water
  4. additionwas added
  5. extractionThe resulting mixture was extracted with EtOAc
  6. washthe combined organic extracts were washed with brine
  7. dry with materialdried over MgSO4
  8. concentrationconcentrated
  9. customto give an orange solid
  10. customThe title compound was purified by silica gel chromatography (95:3:2 to 85:13:2 CH2Cl2/MeOH/NH3)
  11. customto yield a yellow solid
  12. customA yellow precipitate formed
  13. filtrationthe solid was then filtered
  14. washwashed with ether (2 mL)

出典と根拠

ORDレコード
ord-0195ea04746f412cb61b17917bd28e25
出典データセット
uspto-grants-2013_07
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08481525B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート